Tesaro

Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says
Fierce Pharma
Thu, 07/13/17 - 09:33 pm
PARP inhibitors
AstraZeneca
Clovis Oncology
Tesaro
drug pricing
Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?
Investors Business Daily
Mon, 06/19/17 - 07:16 am
AstraZeneca
Clovis
Tesaro
PARP inhibitors
3 Biotech Stocks That Could Become M&A Targets
Motley Fool
Sat, 06/17/17 - 03:05 pm
biotech
M&A
Mallinckrodt
Tesaro
Incyte
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Fierce Pharma
Mon, 06/12/17 - 09:40 pm
Sanofi
Gilead Sciences
Tesaro
M&A
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
drug discounts
drug pricing
Roche
Neurocrine
Sanofi
Regeneron
Tesaro
Novartis
Traders say mergers and acquisitions could bring boost to biotech stocks
CNBC
Fri, 04/14/17 - 10:00 am
M&A
biotech
Tesaro
Incyte
How US Drugmakers Profit From China's Biotech Boom
Investopedia
Thu, 04/13/17 - 11:46 am
China
biotech
Merck
Eli Lilly
Tesaro
Tesaro's PARP inhibitor approved in ovarian cancer
BioPharma Dive
Mon, 03/27/17 - 10:38 pm
Tesaro
ovarian cancer
PARP inhibitors
niraparib
Clovis, Tesaro Soar on Astrazeneca Phase Three News
TheStreet.com
Sat, 02/18/17 - 02:37 pm
Clovis Oncology
Tesaro
AstraZeneca
clinical trials
Lynparza
breast cancer
Tesaro sees a $5B market opportunity for its cancer drug
Bizjournals.com
Fri, 02/17/17 - 10:14 am
Tesaro
niraparib
ovarian cancer
breast cancer
Tesaro shares skyrocket on report of buyout interest from drugmakers
Bizjournals.com
Wed, 02/8/17 - 09:41 pm
Tesaro
M&A
JPM: Day 4 round-up
BioPharma Dive
Fri, 01/13/17 - 12:09 pm
JPMHC 2017
Novavax
Tesaro
MannKind
3 Potential Acquisition Targets for Gilead Sciences, Inc.
Motley Fool
Wed, 11/16/16 - 10:00 pm
Gilead Sciences
Kite Pharma
Tesaro
Intercept Pharma
M&A
Trump presidency could prove a salve for pharma merger deals
Yahoo/Reuters
Fri, 11/11/16 - 09:45 am
Donald Trump
M&A
Pfizer
Valeant Pharmaceuticals
biotech
Sarepta Therapeutics
Tesaro
These 3 Little Biotechs Just Scored Big
Motley Fool
Tue, 10/11/16 - 09:33 pm
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
Tesaro Enjoys A 'Ta-Dah' Moment
Seeking Alpha
Mon, 10/10/16 - 04:20 pm
Tesaro
ovarian cancer
niraparib
Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows
TheStreet.com
Sat, 10/8/16 - 03:49 pm
Tesaro
ovarian cancer
niraparib
Is Tesaro Another M&A Target? The Charts Say It Is
TheStreet.com
Thu, 09/22/16 - 09:17 am
Tesaro
M&A
Gilead Sciences, Inc. Can Fancy TESARO Inc for Acquisition
Bidness, ETC
Tue, 09/13/16 - 11:38 am
Gilead Sciences
PARP inhibitors
Tesaro
M&A
niraparib
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
biotech
M&A
Biomarin
Incyte
Tesaro

Pages